Stock Fundamentals

Company Information

Company Name
Phapros Tbk PT
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
JK
ISIN: ID1000147507
Currency: IDR
Full Time Employees: 1,262
Phone: 62 21 576 2709
Fiscal Year End: December
Description:

PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides ethical generic and branded products; and medical devices, as well as toll manufacturing. It also exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of PT Kimia Farma Tbk.

Address:

Menara Rajawali Lantai 17, Jakarta Selatan, Indonesia, 12950

Directors & Officers

Name Title Year Born
Ms. Intan Abdams Katoppo President Director NA
Mr. Ferdinand Troedu Director of Finance, Risk Management & Human Resources NA
Mr. Erfan Rio Prananto General Manager of Accounting NA
Mr. Maraja Jeson Siregar Director of Marketing & Director NA
Mr. Riza Effendi Head of Internal Control Unit 1969
Mr. Diah Istantri Head of Risk Management Department NA
Ms. Zahmilia Akbar Corporate Secretary 1988

Shares Statistics

Shares Outstanding: 840.00M
Shares Float: 275.27M
% Insiders: 7,313.50%
% Institutions: 0.00%

Valuation Metrics

Enterprise Value: $790.64B
Trailing P/E: 6.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $211.68B
EBITDA: $170.87B
P/E Ratio: $6.00
Book Value: $495.30
Earnings/Share: $41.99
Profit Margin: 3.67%
Operating Margin: 5.96%
ROA (TTM): 5.63%
ROE (TTM): 8.37%
Revenue (TTM): $961.30B
Revenue/Share (TTM): $1.14K
Earnings Growth (YOY): 92.90%
Revenue Growth (YOY): 10.20%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.29x 1.70x 0.69x 1.76x 5.19x
2024-12-31 0.95x 1.96x 0.73x -5.02x -2.63x
2023-12-31 1.28x 1.06x 0.56x 1.10x 6.61x
2022-12-31 1.34x 1.11x 0.57x 1.61x 5.37x
2021-12-31 1.30x 1.20x 0.60x 1.15x 5.84x
2020-12-31 0.94x 1.25x 0.61x 1.68x 4.27x
2019-12-31 1.01x 1.26x 0.61x 3.08x 4.32x
2018-12-31 1.04x 1.08x 0.58x 4.31x 3.35x
2017-12-31 4.14x 0.31x 0.40x 10.49x 1.06x
2016-12-31 3.01x 0.16x 0.30x 6.01x 0.63x
2015-12-31 2.88x 0.25x 0.34x 5.64x 0.99x
2014-12-31 2.57x 0.29x 0.36x 4.80x 1.36x
2013-12-31 2.32x 0.32x 0.39x 9.67x 1.79x
2012-12-31 3.04x 0.18x 0.33x 13.63x 0.65x
2011-12-31 4.15x 0.06x 0.27x 42.05x 0.22x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PEHA.JK!